Health Products

Teva Ramipril (2.5 mg and 5 mg)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
Lot 35320870B
Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Teva-Ramipril 5 mgCapsuleDIN 022479465 mg
Lot 35323175B
Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
A. Teva Ramipril 2.5 mgCapsuleDIN 022479452.5 mg

Introduction

Recalled Products

A. Teva Ramipril 2.5 mg
B. Teva-Ramipril 5 mg

Reason

Confirmed OOS total impurities for the product at the 18 month stability time point.

Depth of distribution

Product was distributed to wholesalers and retail pharmacists in Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec and Saskatchewan. The product was also distributed to educational programs in Manitoba, and in Ontario as gifts and for reasons of compassion.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime